loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 12157 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ORPHENADRINE CITRATE (1)

filter

01 BAUSCH (1)

filter

01 TABLET, EXTENDED RELEASE;ORAL (1)

filter

01 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (1)

URL Supplier Web Content
TABLET, EXTENDED RELEA...
100MG **Federal Regist...
NORFLEX
USA
12157
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 12157

Looking for CTD TGA MCC DOSSIER APPLICATION 12157 1

19

Bausch & Lomb Incorporated, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ORPHENADRINE CITRATE, with a corresponding application number 12157 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Bausch & Lomb Incorporated's NORFLEX TABLET, EXTENDED RELEASE;ORAL, medication with 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of ORPHENADRINE CITRATE.

Post Enquiry
POST ENQUIRY